Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
1024 Dittman Court, , Beech Island, SC, 29842, US
Sterling will manufacture cGMP clinical material for KIVU-107 at its bioconjugation facility in Deeside, UK.
Mark DaFonseca is a seasoned CDMO and pharmaceutical services executive with nearly 30 years of pharmaceutical industry experience.
By: Charlie Sternberg
Will add upstream and downstream GMP processing capabilities to meet increasing demand for 2000L scale single-use biologics manufacturing.
They offer comprehensive GMP manufacturing capabilities to support your pharmaceutical development needs.
Released By Upperton
The expansion adds 8,075 square feet of state-of-the-art GMP manufacturing space to the San Diego biologics manufacturing facility.
Released By Bora Biologics
CellProthera will tech transfer to CELLforCURE by SEQENS this year, with plans to produce clinical batches starting in 2026.
By: Rachel Klemovitch
This will support the development of mRNA-based vaccines and improve access in low- and middle-income countries.
AGC’s ProntoLVV platform to support Quell in advancing Treg cell therapies toward clinical trials.
Partnership aims to advance Fractyl Health’s Rejuva pancreatic gene therapy platform for the treatment of patients with obesity and type 2 diabetes.
A key focus of the partnership will be the development of adeno-associated virus (AAV) gene therapy programs using intellectual property from KU Leuven.
Provides ReciBioPharm’s customers with access to NewBiologix’s Xcell-Eng-HEK293 cell lines to develop and manufacture AAV Therapeutics.
The partnership will prepare for Phase I preparations for Novelty Nobility’s bispecific antibody drug candidate.
How Ardena’s integrated services, nanomedicine expertise, and North American expansion are advancing drug development for oncology, rare diseases, and complex therapies.
By: Tim Wright
Part 1 of 2: Formulation Development for Optimal Dissolution
By: Kyle Rowinski, Connor Polodna, Kristen Placker
Why the current CDMO model is failing small-batch manufacturing and what needs to be done.
By: Sam Chia
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
